BIOENERGENIX has a total of 29 patent applications. Its first patent ever was published in 2010. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Brazil. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are C&C RES LABORATORIES, INI SANTIAGO and VIA PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | Australia | 3 | |
#3 | Brazil | 3 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | New Zealand | 3 | |
#6 | China | 2 | |
#7 | Republic of Korea | 2 | |
#8 | Canada | 1 | |
#9 | EAPO (Eurasian Patent Organization) | 1 | |
#10 | Hong Kong | 1 | |
#11 | Hungary | 1 | |
#12 | Israel | 1 | |
#13 | Mexico | 1 | |
#14 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Mccall John M | 23 |
#2 | Romero Donna L | 15 |
#3 | Mckearn John | 9 |
#4 | Romero Donnal L | 9 |
#5 | Kelly Robert C | 7 |
#6 | Clare Michael | 7 |
#7 | Clair Michael | 2 |
#8 | Mccall John | 2 |
#9 | John M Mccall | 2 |
#10 | John Mckearn | 2 |
Publication | Filing date | Title |
---|---|---|
WO2014066743A1 | Heterocyclic compounds for the inhibition of pask | |
WO2012119046A2 | Heterocyclic compounds for the inhibition of pask | |
EP2661431A2 | Heterocyclic compounds for the inhibition of pask | |
AU2010289397A1 | Heterocyclic compounds for the inhibition of PASK |